EMA Authorised: Optison (perflutren) — GE Healthcare AS

View source ↗

Summary

Optison (perflutren) has been authorised in the EU for use in echocardiography.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Universal Echocardiography Indication

Drugs mentioned

• Optison

Snippet

Status: Authorised. Therapeutic area: Echocardiography. MAH: GE Healthcare AS. Decision date: 19/05/2022